You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Metastases

Apalutamide with androgen deprivation therapy for treating hormone-sensitive metastatic prostate cancer

  • Technology appraisal guidance
  • Reference number: TA741
  • Published:  28 October 2021
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History
{"Message":"No stream returned from blob store for id 2497cecd-681d-486f-ab15-b0fe2c83be25","StatusCode":"InternalServerError"}
  • Appraisal consultation document (PDF version) (PDF 476 KB)

    Published:
    20 May 2021
  • Appraisal consultation document (online commenting)

  • Committee papers (PDF 9.47 MB)

    Published:
    20 May 2021
  • Committee papers slides (PDF 2.1 MB)

    Published:
    20 May 2021

This page was last updated: 04 November 2021

Back to top